SABS - SAB Biotherapeutics, Inc.

1.6901
0.020   1.189%

Share volume: 57,765
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$1.67
0.02
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 05-15-2023 08-21-2023 11-13-2023 03-29-2024 05-20-2024 08-08-2024 11-06-2024
Total revenue 581.101 K 85.518 K 1.267 M 305.011 K 944.575 K 263.137 K 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 581.101 K 85.518 K 1.267 M 305.011 K 944.575 K 263.137 K 0.000
    -85.28% 1,381.98% -75.93% 209.69% -72.14% -100.00%  
Operating expenses 7.983 M 6.562 M 6.590 M 19.179 M 12.335 M 10.465 M 11.309 M
Selling general and admin 3.447 M 2.900 M 2.571 M 14.881 M 4.189 M 3.643 M 3.479 M
Research and development 4.536 M 3.662 M 4.020 M 4.297 M 8.146 M 6.822 M 7.831 M
Total expenses 7.983 M 6.562 M 6.590 M 19.179 M 12.335 M 10.465 M 11.309 M
    -17.80% 0.43% 191.02% -35.68% -15.16% 8.07%  
Operating income -7.402 M -6.477 M -5.323 M -18.874 M -11.391 M -10.202 M -11.309 M
Ebit -7.402 M -6.477 M -5.323 M -18.874 M -11.391 M -7.617 M -10.549 M
Pretax income -7.354 M -6.881 M -5.102 M -22.857 M -5.026 M -7.335 M -10.349 M
    -6.43% -25.85% 347.97% -78.01% 45.96% 41.09%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -7.354 M -6.881 M -5.102 M -22.857 M -5.026 M 0.000 0.000
    6.43% 25.85% -347.97% 78.01% 100.00%    
Net income -7.354 M -6.881 M -5.102 M -22.857 M -5.026 M -7.335 M -10.349 M
    6.43% 25.85% -347.97% 78.01% -45.96% -41.09%